Johnson & Johnson (NYSE:JNJ) is commencing today, through a new wholly owned subsidiary, Maple Merger, Sub, Inc., a cash tender offer to purchase all outstanding shares of common stock of Mentor Corporation (NYSE:MNT). Johnson & Johnson reported on December 1, 2008 its intent to acquire Mentor.
Huntsman continues multi-billion dollar Texas lawsuit against Credit Suisse and Deutsche Bank
PACK & GIFT 2009 – 2nd edition 3 & 4 June 2009 at Paris – Porte de Versailles – A convincing original and effective concept! – Placing sustainability and responsibility at the heart of the event – A wide range of markets concerned
– Revenues of $1.6 million and a net loss of $1.2 million for the quarter
Expands Ability To Provide Coast-To-Coast Print Management Services With New Commercial Printing Facility In Toronto And Enhanced Resources In Western Canada
Johnson & Johnson (NYSE:JNJ) today announced that the Israeli General Director of the Antitrust Authority has approved Johnson & Johnson’s proposed acquisition of Omrix Biopharmaceuticals, Inc. (NASDAQ:OMRI), under the Restrictive Trade Practices Law 5748-1988 of Israel.
As of 10 December 2008 Schur International a/s has acquired all shares in IDAB WAMAC International AB from Heidelberger Druckmaschinen AG.
